Emergent BioSolutions Expands NARCAN Nasal Spray Distribution Capabilities Nationwide
Portfolio Pulse from Benzinga Newsdesk
Emergent BioSolutions Inc. (NYSE:EBS) has announced the opening of a new NARCANDirect™ distribution center in Nevada to enhance the nationwide distribution of NARCAN® Nasal Spray. This move aims to meet the growing demand for naloxone and ensure faster delivery to various public interest customers.
August 06, 2024 | 12:16 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Emergent BioSolutions Inc. has opened a new NARCANDirect™ distribution center in Nevada to improve the nationwide distribution of NARCAN® Nasal Spray, aiming to meet the increased demand for naloxone.
The new distribution center in Nevada will likely improve the supply chain efficiency and meet the growing demand for NARCAN® Nasal Spray, positively impacting EBS's revenues and market position.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100